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Edited by Lukas HuberAbstract Oxidative stress is one of the factor contributing to
blood brain barrier degeneration. This phenomenon is observed
during pathological conditions such as Alzheimer’s disease or
cerebral amyloid angiopathy in which brain haemorrhages are
very frequent. Both diseases are characterized by beta amyloid
peptide deposition either in neurons or in vessels. Oxidative
stress leads to impairment of mitochondrial functions and apop-
totic cell death subsequent to caspases activation. In this paper
we demonstrate that BH4 domain of Bcl-xl administrated to
endothelial cells as the conjugated form with TAT peptide, re-
verts Ab-induced apoptotic cell death by activating a survival
programme which is Akt/endothelial nitric oxide synthase depen-
dent.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Cerebral amyloid angiopathy1. Introduction
Increased oxidative stress contributes to the decline in cogni-
tive functions during neurodegenerative conditions such as
Alzheimer’s disease (AD). AD has a characteristic neuropa-
thology consisting of senile plaques, neuroﬁbrillary tangles,
cerebrovascular b-amyloidosis and selective neuronal loss [1].
One of the main constituents of the plaques and cerobrovascu-
lar amyloid deposits is beta-amyloid peptide (Ab) [2]. In addi-
tion to the deposition in the brain parenchyma, Ab
accumulates in cerebral blood vessels and is a major cause of
haemorrhagic and ischemic strokes in AD [3].
Several studies demonstrated that Ab-induced toxicity is
mediated by reactive oxygen species (ROS) generation that di-
rectly damage brain endothelium and caused apoptotic cell
death which involved mitochondrial dysfunction and caspase
activation [4].
The apoptotic process is executed by cysteine proteases
(caspases) and regulated by pro-apoptotic and anti-apoptotic
members of Bcl-2 protein family [5]. The proteins of this family
are characterised by four diﬀerent homology domains called
Bcl-2 homology (BH) domains: BH1, BH2, BH3 and BH4,
of which only BH4 has anti-apoptotic properties. Previous
studies demonstrated that Bcl-xL acts by its BH4 domain in
inhibiting cytocrome c release and the mitochondrial mem-*Corresponding author. Fax: +39 0577 234343.
E-mail address: cantara@unisi.it (S. Cantara).
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[6,7]. We demonstrated that BH4 domain administrated to
endothelial cells as the conjugated form with TAT peptide,
inhibited endothelial cell death induced by oxidative stress [8].
In this study we focused our attention on the possibility to
revert Ab-induced apoptotic cell death by exogenous adminis-
tration of TAT-BH4 peptide to culture endothelial cells (EC).
We demonstrate that TAT-BH4 reverts endothelial cell death
by activating a survival programme which is Akt/endothelial
nitric oxide synthase (eNOS) dependent.2. Materials and methods
2.1. Cell culture
Post-capillary venular endothelial cells (CVEC) were obtained by
using a bead-perfusion technique through the coronary sinus of bovine
heart and cultured in DMEM (Sigma) supplemented with 10% bovine
calf serum (BCS, Hyclone) and antibiotics (100 U/ml penicillin, 100 lg/
ml streptomycin) on gelatine coated dishes as previously described [9].
Cells between passage 18 and 20 were used.
2.2. Cell growth
1.5 · 103 cells resuspended in 10% serum were seeded in each well of
96-multiwell plates. After adherence, cells were starved (0.1% BCS) for
24 h. After, cells were incubated with Ab140 or Ab142 (0.5–5–50 or
100 lM) in the presence/absence of MnTBAP or Tiron (100 lM) or
H2O2 50 lM. TAT-BH4 and its scrambled sequence were tested at
50 nM [8]. After 48 h, cells were ﬁxed in 100% methanol and stained
with Diﬀ-Quik (Mertz-Dade). Total cell number/well was counted at
10· magniﬁcation. Reverse sequence Ab401 was tested at 50 lM.
2.3. MTT assay
1.5 · 103 cells resuspended in 10% serum were seeded in each well of
96-multiwell plates. After adhesion, cells were serum starved overnight
and then stimulated with 5 lMAb140 or Ab401 or Ab142 alone or in
combination with 100 lM DEVD-CHO added 1 h before the addition
of the stimuli. Cells were exposed to test substances for 18, 24 or 48 h.
Four hours before the end of the incubation time, 100 ll of 12 mM
MTT stock solution were added to each well. After the medium was
removed and 50 ll of DMSO were added to each well for 10 min.
The absorbance was measured by using SpectraFluor (Tecan) at
540 nm.
2.4. Reactive oxygen species detection
Intracellular ROS were detected using the dye 2,7-dichlorodihydro-
ﬂuorescein diacetate (DCFH2-DA; Molecular Probes) as a ﬂuorescent
probe. CVEC were seeded in a 96-multiwell plate at 1.5 · 103 cells/ml.
After attachment, cells were starved for 18 h and then stimulated
with Ab140 (5 lM) for 18, 24 or 48 h. After washing three times with
PBS, cells were incubated with 100 lM DCFH2-DA for 20 min.
DCFH2-DA is rapidly oxidized to the highly ﬂuorescent component
2,7-dichloroﬂuorescein (DCF) under oxidative stress. Following exten-
sive washing in PBS, intracellular levels of ROS were evaluated photo-
metrically with a microplate reader (excitation/emission 495/527)
(SpectraFluor, Tecan).blished by Elsevier B.V. All rights reserved.
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4 · 105 cells were plated in 10% serum, starved for 24 h, and then
stimulated with test substances (Ab140 or its reverse-sequences at
5 lM, H2O2 at 200 lM, TAT-BH4 or scrambled peptide at 50 nM,
and Tiron at 100 lM) for 18 h. Enzyme activity was detected in super-
natants by measuring the proteolytic cleavage of ﬂuorogenic substrate
of caspase-3 (Z-DEVD-R110) in assay buﬀer provided by the kit. The
ﬂuorescence was measured (excitation/emission 485/535) every 30 min
within 3 h.Fig. 1. 5 lM Ab140 were given to cells for 18 h and apoptotic cell death w
compare to control (green ﬂuorescence). Total cell number was counterstainin
magniﬁcation at 400·.
Table 1
Ab peptides aﬀect endothelial cell growth dose-dependently
Ab peptides concentrations (lM) Ab140 Ab142 Ab401
Cell growth (% of basal response)
0.5 120 ± 4 80 ± 11 n.d.
5 71 ± 2* 62 ± 5* n.d.
50 60 ± 3* 35 ± 4** 102
100 51 ± 6** 24 ± 7** n.d.
Endothelial cell growth evaluated in post-capillary endothelial cells
(CVEC) exposed to increasing concentrations of Ab140 or Ab142
(0.5–100 lM) for 48 h. Data are reported as percentage of basal
response (referred to be 100) ± S.E.M. (n = 4 experiments run in trip-
licate). *P < 0.05 vs. basal, **P < 0.01 by Student’s t-test. S.E.M. value
for Ab40-1 was not signiﬁcative compared to control.
Table 2
Cell survival decreases over time upon incubation with Ab140 peptide
Incubation time (h) none +Ab140 + Ab401
MTT reduction (% of inhibition vs. control values)
18 100 ± 4 34 ± 4* 81 ± 8
24 100 ± 7 54 ± 5** 100
48 100 ± 2 61 ± 6** 112 ± 3
Time course of 5 lM Ab140-induced toxicity measured by MTT test.
* P < 0.01 and **P < 0.001 vs. control by Student’s t-test. Reverse
peptide tested at 50 lM.2.6. Tunel assay
Apoptosis was determined by using ApopTag Plus Fluorescein In
Situ Apoptosis Detection Kit (Chemicon) following kit protocol.
Brieﬂy, 25 · 103 CVEC cells were seeded on cover slides in a 24-multi-
well plate. Cells were starved for 24 h and then stimulated with Ab140
(5 lM) for 18 h. Cells were counterstained with DAPI as indicated by
the kit. Original magniﬁcation was at 400·.
2.7. Western blot
3 · 105 CVEC were plated in 60 mm diameter dishes. After adhesion
cells were serum starved for 24 h, then exposed to Ab140 (5 lM) in the
presence/absence of TAT-BH4 (50 nM) for 15 min. After incubation
western blots were performed as described [8]. Primary polyclonal anti-
body against pAkt (Cell Signalling) was used at 1:1000 dilution. Re-
sults were normalized to those obtained by using anti actin antibody
(1:10000, Sigma).
2.8. Determination of nitric oxide (eNO) synthase activity
NOS activity was measured in CVEC using the citrulline assay as
previously described [10]. Cells were stimulated with Ab140 (5 lM)
or TAT-BH4 (50 nM) or LY294002 (10 lM) alone or in combination
for 15 min. Cpm values obtained from plates treated with L-NMMA
were subtracted from each experimental point. NO synthase activity
is expressed as percent of basal response.
2.9. Reagents
The beta peptides (Ab140, Ab142), reverse sequence Ab401, Tiron
and MTT, H2O2, LNMMA and cell culture reagents are from Sigma.
MnTBAP and DEVD-CHO are from Calbiochem. TAT-BH4 is from
Oncogene. Scrambled peptide TAT4957-(SKQVLYNSGRVELK-
YDFSLS) is synthesized in collaboration with Prof. M. Taddei (Dipar-
timento Farmaco Chimico Tecnologico, University of Siena, Italy).
Phospho-Akt antibody is from Cell Signalling and anti-actin antibody
was purchased from Calbiochem.
2.10. Statistical analysis
Results are expressed as means ± S.E.M. Statistical analysis were
performed using Student’s t-test, and analysis of variance (ANOVA).
P < 0.05 was considered signiﬁcant.as measured by Tunel assay. Apoptosis was increased in treated cells
g with DAPI which stained cell nuclei in blue (lower pictures). Original
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3.1. Ab peptides inhibit endothelial cell survival
Treatment of microvascular endothelial cells (CVEC) with
0.5–100 lMAb peptides for 48 h aﬀected CVEC ability to pro-
liferate and increased cell death in a dose dependent manner
(Table 1). At 0.5 lM we did not observe any modiﬁcation in
endothelial cell proliferation compared to control (basal re-
sponse in 0.1% serum referred to be 100). CVEC growth was
inhibited starting from 5 lM for both peptides (P < 0.05),
however Ab142 showed more toxicity than the shorter form
Ab140. Toxic eﬀects were speciﬁcally mediated by Ab peptides
as the reverse sequence (Ab401 at 50 lM) did not alter cell
proliferation and did not cause cell death (99 ± 4 and
102 ± 6 vs. 107 ± 3 of basal control, respectively) (Table 1).
The inhibition in cell survival mediated by Ab peptides admin-
istration were also time dependent as conﬁrmed by MTT as-
say. As shown in Table 2, cell survival decreased over time
(18, 24 and 48 h) after exposure to 5 lM Ab140. Moreover,
Ab140-induced cell death was measured by Tunel assay in
CVEC exposed to Ab140 (5 lM) for 18 h. Ab140 application
decrease cell number and increase caspase-3-related ﬂuores-
cence (Fig. 1 second panel) compared to control (Fig. 1 ﬁrst
panel).Fig. 2. (A) ROS production was measured in CVEC by monitoring the
oxidation of intracellular H2DCFDA upon stimulation with Ab140
(5 lM) or Tiron or MnTBAP (100 lM) for 18, 24 or 48 h. Results are
expressed as relative ﬂuorescence (fold increase) ± S.E.M. (n = 2 run in
triplicate). *P < 0.01 vs. basal production, #P < 0.01 vs. Ab140-
induced ROS production by Student’s t-test. (B). 5 lM Ab140 or
Ab142 were given to cells in the presence/absence of 100 lM Tiron or
MnTBAP for 48 h. Results are expressed as cell number (percentage of
basal response) ± S.E.M. (n = 3 run in triplicate). #P < 0.05 vs. basal
control, *P < 0.05 vs. Ab140-induced cell death, **P < 0.01 vs. Ab142-
induced toxicity respectively, by Student’s t-test. (C). Caspase-3
activation after treatment with 5 lM Ab140 for 18 h. Results are
expressed as relative ﬂuorescence/mg protein ± S.E.M. (n = 2 run in
triplicate). *P < 0.01 vs. 0.1% BCS by Student’s t-test (D). Cell survival
was evaluated after 48 h exposure with 5 lM Ab142 or Ab140 by
MTT test. *P < 0.05 vs. 0.1% BCS and #P < 0.05 vs. cell survival
inhibition induced by Ab peptides by Student’s t-test.3.2. Ab peptides induce ROS formation and consequently
caspase-3 activation
It is known that Ab peptides induce ROS formation in many
cell types [11,12]. We hypothesized that ROS were responsible
for cell death in our model of cultured endothelium. To verify
this hypothesis we measured ROS production in CVEC stimu-
lated with Ab140 (5 lM) for 18, 24 or 48 h by monitoring the
oxidation of intracellular H2DCFDA. ROS production was
increased in treated cells over time compared to control condi-
tion (0.1% BCS) (Fig. 2A) and this eﬀect was abolished in the
presence of commercial scavengers (Tiron or MnTBAP both at
100 lM). To verify that this production was responsible for
diminished cell growth observed at 48 h, CVEC were treated
with 5 lM Ab140 or Ab142 in the presence/absence of Tiron
or MnTBAP (100 lM). As shown in Fig. 2B, treatment with
Ab140 or Ab142 (5 lM) reduced cell number compared with
control in 0.1% BCS (71 ± 8 and 62 ± 7 vs. 100 ± 9 of control).
Administration of ROS scavenger 15 minutes before the addi-
tion of Ab peptides reduced cell loss and restored cell number
at control level (Tiron: 107 ± 4 for Ab140 and 108 ± 3 for
Ab142; MnTBAP: 111 ± 5 for Ab140 and 102 ± 3 for
Ab142). ROS production leads to caspase-3 activation and
consequently apoptotic cell death [13]. We then investigated
whether Ab peptides-induced toxicity was mediated by cas-
pase-3 activation. 5 lM Ab140 induced caspase-3 activation
after 18 h (Fig. 2C) with an increase of about 20% over control
(Ab1406647 ± 245, 0.1% BCS 4591 ± 200 relative ﬂuorescence
units). The extent was comparable with 200 lM H2O2
(7652 ± 249 relative ﬂuorescence units) known for its activity
in inducing ROS formation [8]. Reverse-sequences did not af-
fect caspase-3 activity (Fig. 2C). To better clarify the role of
caspase-3 in Ab peptides-inhibited cell survival, a speciﬁc cas-
pase-3 inhibitor (DEVD-CHO) was used. 100 lM DEVD-
CHO (which is not toxic per se) (Fig. 2D), in combination with
5 lM Ab142 or Ab140 were added to plates. As shown
in Fig. 2D cell viability was rescued by blocking caspase-3
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respectively vs. 0.1516 of basal control, Abs at 540 nm 0.172
and 0.1833 for Ab142 or Ab140 in the presence of DEVD-
CHO respectively vs. 0.1516 of basal control), indicating that
caspase-3 represents a key player for Ab-induced endothelial
cell death.
3.3. TAT-BH4 inhibits Ab-peptides-induced apoptotic cell death
Following the hypothesis that Ab-induced EC death is
due to ROS formation, we tested the eﬀect of TAT-BH4 in
inhibiting caspase-3 activation and in restoring cell ability to
proliferate. As shown in Fig. 3A 50 nM TAT-BH4 blocked
caspase-3 activation induced by 5 lM Ab140 after 18 h
(Ab140 6647 ± 245, TAT-BH4 + Ab140 3987 ± 199). As
expected, similar results were obtained with Tiron, the
commercial ROS scavenger (Tiron + Ab140 4195 ± 196).
The observed response was speciﬁc for the TAT-peptide as
its scrambled sequence did not show any eﬀect (Fig. 3A). To
explore whether TAT-BH4 could contribute to improve cell
survival after Ab-peptides exposure, we treated endothelial
cells for 48 h with 5 lMAb140 which induced toxicity and cell
death (Fig. 3B). The co-administration with 50 nM TAT-BH4
restored cell proliferation which was not positively aﬀected by
the scrambled peptide (Fig. 3B).
3.4. TAT-BH4 restores Akt/eNOS pathway
As endothelial cell survival is strictly linked with nitric oxide
(NO) production [9] and Ab has been demonstrated to inhibit
nitric oxide synthase (NOS) activity [14,15], we analysedFig. 3. (A) CVEC were stimulated with 5 lM Ab140 for 18 h in the
presence/absence of TAT-BH4 (50 nM) or Tiron (100 lM). Results are
expressed as caspase-3 activity (relative ﬂuorescence/mg pro-
tein) ± S.E.M. (n = 2 run in triplicate). *P < 0.001 and **P < 0.0001
vs. basal response, #P < 0.001 or @P < 0.0001 vs. H2O2- or Ab140-
induced caspase-3 activation, respectively, by ANOVA. (B). Eﬀect of
TAT-BH4 and its scrambled sequence on endothelial cell growth after
exposure to 5 lM Ab140 for 48 h. Results are expressed as % of basal
response ± S.E.M. (n = 3 run in triplicate). *P < 0.01 vs. basal
response, #P < 0.0001 or @P < 0.0001 vs. H2O2- or Ab140-induced
cell death by ANOVA, respectively.
Fig. 4. (A) CVEC were treated with Ab140 (5 lM) for 15 min and
then Akt phosphorylation was revealed by western blotting. A
representative gel out of three obtained with similar results is shown.
Bar graph represents the mean of three experiments expressed as OD
arbitrary units (phospho-Akt/actin). *P < 0.05, **P < 0.01 vs. 0.1%
BCS and #P < 0.01 vs. Ab140 eﬀect on Akt phosphorylation by
ANOVA. (B) eNOS activity measured in CVEC after 15 min in the
presence of Ab140 (5 lM). The eﬀect of TAT-BH4 was determined in
the presence/absence of LY294002, a commercial Akt inhibitor.
Results are expressed as eNOS activity(percentage over control) ±
S.E.M. (n = 3). *P < 0.001 vs. control, #P < 0.05 vs. Ab140 and
@P <
0.05 vs. TAT-BH4 + Ab140, by ANOVA.whether TAT-BH4 was able to restore eNOS function. It is
known that eNOS is subsequently activated by its interaction
with Akt which is responsible for eNOS phosphorylation
[16]. We investigated Akt phosphorylation in CVEC after
15 min of treatment with Ab140 (5 lM) in the presence/ab-
sence of TAT-BH4 (50 nM). We observed that Ab140 signiﬁ-
cantly (p < 0.05) reduced Akt phosphorylation and this eﬀect
was reverted after exogenous administration of TAT-BH4
(Fig. 4A). We then investigated the eﬀect of TAT-BH4 on
Ab140 -induced eNOS inhibition. As shown in Fig. 3B,
Ab140 reduced eNOS activity (p < 0.001) and co-stimulation
with TAT-BH4 restored eNOS function after 15 min
(p < 0.01). We also demonstrated that pharmacological inhibi-
tion of Akt with LY294002 (10lM) blocked TAT-BH4 eﬀect
on eNOS, revealing that TAT-BH4 activity is dependent on
Akt phosphorylation (Fig. 4B).4. Conclusion
Endothelial cells lining the cerebral capillaries have
tight junctions forming the blood–brain barrier (BBB). Under
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rendering it impermeable to cells, compounds and many bio-
logically active macromolecules [17]. In the AD brain, cerebro-
vascular endothelial cells are damaged and this results in a loss
of function of the BBB which becomes permeable to plasma
constituents, neurotoxic agents and to blood-circulating Ab
peptides. These events contribute to neuronal Ab deposition
and further induce neuronal death.
The results described above demonstrate that endothelial
cells undergo apoptosis when exposed to Ab140/42. Speciﬁ-
cally, Ab peptides in a micromolar range inhibit ECs replica-
tion in a concentration and time dependent manner. As
shown, the eﬀect is amyloid dependent, as the reverse peptides
do not aﬀect endothelial ability to proliferate.
The mechanism responsible for endothelial death is the pro-
duction of reactive oxygen species (ROS). ROS contribution is
revealed both by measuring the oxidation of intracellular
H2DCFDA or by using commercial scavengers which were
able to restore endothelial cell viability. ROS production is fol-
lowed by caspase-3 activation [13]. 5 lM Ab140 given to cells
for 18 h induced caspase-3 to an extent comparable to that
produced by H2O2 at 200 lM. Using a commercial caspase-3
inhibitor (DEVD-CHO) we demonstrate that the loss in endo-
thelial cell survival is dependent upon caspase-3 activation, as
evidenced by MTT test. In light of this, oxidative injury may
be one of the mechanism by which Ab peptides exert their
cytotoxic eﬀects.
It is known that apoptosis results from an imbalance be-
tween anti-apoptotic and pro-apoptotic proteins. Shimizu
et al. [6] have demonstrated that the BH4 domain is necessary
for Bcl-xL to exert its anti-apoptotic eﬀect. Previous results ob-
tained in our laboratory [8], have shown that TAT-BH4 re-
duces endothelial cell death induced by H2O2 by inhibiting
the apoptotic pathway.
In this study we analyze the possibility to use TAT-BH4 as
pharmacological tool to prevent endothelial damage induced
by Ab deposition. The results obtained demonstrate that
50 nM TAT-BH4 is able to block Ab140-induced capsase-3
activation as well as the commercial scavenger Tiron and re-
store endothelial cell growth. The eﬀect is speciﬁc for TAT-
BH4 as the scrambled peptide does not aﬀect Ab-induced
endothelial cell death. We suggest that TAT-BH4 eﬀect is re-
lated to Akt. In fact, Ab140 inhibits Akt phosphorylation
and consequently eNOS activity leading to diminished NO
production which in turn may be responsible for impaired
endothelium. TAT-BH4 counteracts Ab140 eﬀect on Akt, thus
restoring eNOS activity.
Taken together these results suggest the possibility to char-
acterize TAT-BH4 as a new pharmacological agent capable
to restore endothelial viability and consequently BBB function
thus contributing to the treatment of AD.
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